CA2615926A1 - 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof - Google Patents

3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof Download PDF

Info

Publication number
CA2615926A1
CA2615926A1 CA002615926A CA2615926A CA2615926A1 CA 2615926 A1 CA2615926 A1 CA 2615926A1 CA 002615926 A CA002615926 A CA 002615926A CA 2615926 A CA2615926 A CA 2615926A CA 2615926 A1 CA2615926 A1 CA 2615926A1
Authority
CA
Canada
Prior art keywords
cyclohex
dimethylamino
methyl
formula
crystalline form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002615926A
Other languages
English (en)
French (fr)
Inventor
Michael Gruss
Wolfgang Hell
Martin Szelagiewicz
Joerg Berghausen
Susan Margaret De Paul
Markus Von Raumer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2615926A1 publication Critical patent/CA2615926A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA002615926A 2005-07-22 2006-07-20 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof Abandoned CA2615926A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005034974.9 2005-07-22
DE102005034974A DE102005034974A1 (de) 2005-07-22 2005-07-22 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
PCT/EP2006/007160 WO2007009792A1 (de) 2005-07-22 2006-07-20 3-(2-(dimethylamino)methyl-(cyclohex-1-yl))phenol-maleat und dessen kristalline formen

Publications (1)

Publication Number Publication Date
CA2615926A1 true CA2615926A1 (en) 2007-01-25

Family

ID=37084866

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002615926A Abandoned CA2615926A1 (en) 2005-07-22 2006-07-20 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof

Country Status (25)

Country Link
EP (1) EP1881956B1 (enExample)
JP (1) JP5205259B2 (enExample)
KR (1) KR20080033436A (enExample)
CN (1) CN101228110A (enExample)
AR (1) AR057674A1 (enExample)
AT (1) ATE431332T1 (enExample)
AU (1) AU2006271856B2 (enExample)
BR (1) BRPI0614057A2 (enExample)
CA (1) CA2615926A1 (enExample)
CY (1) CY1109208T1 (enExample)
DE (2) DE102005034974A1 (enExample)
DK (1) DK1881956T3 (enExample)
EC (1) ECSP088088A (enExample)
ES (1) ES2326493T3 (enExample)
HR (1) HRP20090412T1 (enExample)
IL (1) IL188897A (enExample)
MX (1) MX2008000743A (enExample)
NO (1) NO20080826L (enExample)
PE (1) PE20070368A1 (enExample)
PL (1) PL1881956T3 (enExample)
PT (1) PT1881956E (enExample)
RU (1) RU2434845C2 (enExample)
SI (1) SI1881956T1 (enExample)
WO (1) WO2007009792A1 (enExample)
ZA (1) ZA200801703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008000070A1 (es) * 2007-01-17 2008-07-25 Lg Life Sciences Ltd Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
PT2240431T (pt) * 2007-12-07 2017-05-03 Gruenenthal Gmbh Modificações cristalinas de (1r,2r)-3-(3-dimetilamino-1- etil-2-metil-propil)fenol
EP2085081A1 (de) 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10218862A1 (de) * 2002-04-26 2003-11-06 Gruenenthal Gmbh Verfahren zur Chlorierung tertiärer Alkohole
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen

Also Published As

Publication number Publication date
PT1881956E (pt) 2009-06-26
MX2008000743A (es) 2008-03-10
DK1881956T3 (da) 2009-09-07
DE502006003728D1 (de) 2009-06-25
EP1881956B1 (de) 2009-05-13
RU2008106455A (ru) 2009-08-27
HRP20090412T1 (hr) 2009-09-30
HK1112612A1 (zh) 2008-09-12
NO20080826L (no) 2008-02-20
IL188897A (en) 2012-12-31
SI1881956T1 (sl) 2009-10-31
ECSP088088A (es) 2008-02-20
EP1881956A1 (de) 2008-01-30
JP5205259B2 (ja) 2013-06-05
PL1881956T3 (pl) 2009-10-30
PE20070368A1 (es) 2007-05-12
ES2326493T3 (es) 2009-10-13
AR057674A1 (es) 2007-12-12
BRPI0614057A2 (pt) 2012-12-11
KR20080033436A (ko) 2008-04-16
CN101228110A (zh) 2008-07-23
CY1109208T1 (el) 2014-07-02
WO2007009792A1 (de) 2007-01-25
JP2009502757A (ja) 2009-01-29
ZA200801703B (en) 2009-08-26
RU2434845C2 (ru) 2011-11-27
ATE431332T1 (de) 2009-05-15
DE102005034974A1 (de) 2007-04-19
IL188897A0 (en) 2008-04-13
AU2006271856B2 (en) 2012-03-01
AU2006271856A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
CN1128805C (zh) 氯吡格雷硫酸氢盐的多晶型物及其制备方法和药物组合物
CN105198775B (zh) 一种手性N‑Boc联苯丙氨醇的制备方法
CN104744394B (zh) 一种不对称合成含三氟甲基手性季碳化合物的方法
FR2875807A1 (fr) Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CA2615926A1 (en) 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof
CN1108029A (zh) 克拉维酸的二胺盐
CN104402793A (zh) 一种3-取代氧化吲哚衍生物及其合成方法和应用
CA2738543A1 (fr) Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CN103167872A (zh) 用于生产l-肉碱酒石酸盐的方法
JP2012511006A (ja) アザビシクロ−トリフルオロメチルベンズアミド誘導体の新規な結晶多形
CN101851181B (zh) 一种1-位取代牛磺酸的制备方法
CN109705048B (zh) 一种戊唑醇的清洁制备方法
KR101853260B1 (ko) 세벨라머 카보네이트의 제조방법
CN102993191B (zh) 一种含有吖内酯与吡唑啉酮的杂环手性化合物及其衍生物、合成方法及用途
CN107382813B (zh) 格列美脲关键中间体的合成方法
CN101880249A (zh) 一种合成叔丁基亚磺酰胺的工艺方法
CN108586257B (zh) 一种对氟硝基苯的制备方法
CN1136200C (zh) 药理活性的对映体及其制备方法
CN107474018B (zh) 一种高活性腈菌唑的制备方法
CN1709859A (zh) 一种制备右旋α-[2-(萘氧基)乙基]苯甲胺衍生物的方法
CN103864739B (zh) 脱氢醋酸钠二水合物及其制备方法
JP2013018776A (ja) 3−[2−(ジメチルアミノ)メチル−(シクロヘキシ−1−イル)]−フェノールのHCl多形体
CN100460387C (zh) 盐酸s-[2-[(1-亚氨基乙基)氨基]乙基]-2-甲基-l-半胱氨酸马来酸盐结晶盐
JP7323876B2 (ja) クロピドグレル硫酸塩のi型結晶の製造方法
CN117586133A (zh) 一种提高精异丙甲草胺原油s构型体的合成工艺

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140918